Healthy Extracts HYEX

OTC HYEX
$1.35 +0.00 (+0.00%)
At close: Aug 17, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap22.06 Mn
P/E-16.17
P/S3.91
Div. Yield0.00
Revenue Growth (1y) (Qtr)113.41
Add ratio to table…

About

Healthy Extracts Inc. is a platform for acquiring, developing, patenting, marketing, and distributing plant based nutraceuticals. The company focuses on high growth categories within the nutraceuticals market such as heart, brain, and immune health. Through its subsidiaries Bergamet, UBN, and HE Gummy USA it offers proprietary products and contract manufacturing services. Its primary geographic market is customers in the United States seeking supplements for heart, brain,…

Read more ↓
Sectors: Consumer Staples · Industrials Sector rationale The company's primary revenue is derived from the sale of plant-based nutraceuticals and health supplements (Bergamet and UBN) sold to consumers via retail partners like Walmart and Amazon, which falls under Personal Care Products or Packaged Foods in Consumer Staples. A secondary sector is justified because the HE Gummy USA subsidiary operates a distinct business line providing contract manufacturing and formulation services to third-party companies, which is an industrial operating service. Industries: Personal Care Products Consumer Staples Primary Healthy Extracts manufactures and markets over-the-counter nutritional supplements for heart, brain, and immune health, such as Bergamet Pro+ and UBN Activate. These products are sold directly to consumers and through retail partners like Amazon and Walmart.com. Industrial Machinery Industrials Secondary Through its HE Gummy USA subsidiary, the company provides contract manufacturing and formulation services for third-party companies in the nutritional supplement and consumer wellness sectors, producing 12 to 15 million dosage units per month. Classified using BQ-MICS CIK: 0001630176

Business Acquisition Breakdown of Revenue (2021)

Business Acquisition Breakdown of Revenue (2021)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 86.50 Bn80.681.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 42.71 Bn61.362.4716.59 Bn
3 ZTS Zoetis Inc. 30.86 Bn11.803.249.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.50 Bn49.630.6131.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.06 Bn16.836.99-
6 VTRS Viatris Inc 18.84 Bn-45.871.2813.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.55 Bn22.034.61-
8 VREOF Vireo Growth Inc. 11.86 Bn-238.0033.850.20 Bn